These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. A double-blind comparison of loxapine succinate and trifluoperazine in newly admitted schizophrenic patients. Simpson GM; Cuculic Z J Clin Pharmacol; 1976 Jan; 16(1):60-5. PubMed ID: 1107360 [TBL] [Abstract][Full Text] [Related]
27. Evaluation of two dose levels of loxapine succinate in chronic schizophrenia. Clark ML; Paredes A; Costiloe JP; Fulkerson FG; Wood F Dis Nerv Syst; 1977 Jan; 38(1):7-10. PubMed ID: 318984 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of loxapine succinate as an anxiolytic in comparison with chlordiazepoxide. Mahal AS; Malik SC; Srinivasamurthy U Curr Ther Res Clin Exp; 1976 Jul; 20(1):84-93. PubMed ID: 821710 [No Abstract] [Full Text] [Related]
30. Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial. Fruensgaard K; Wollenberg J; Hansen KM; Fensbo C; Sihm F Curr Med Res Opin; 1978; 5(8):601-7. PubMed ID: 361345 [TBL] [Abstract][Full Text] [Related]
31. Loxapine versus thioridazine in the treatment of organic psychosis. Versiani M; da Silva JA; Mundim FD J Int Med Res; 1980; 8(1):22-30. PubMed ID: 7358200 [TBL] [Abstract][Full Text] [Related]
32. A study of parenteral loxapine succinate in very disturbed psychotic patients. James B; McIntyre M; Hannah J N Z Med J; 1982 Feb; 95(702):123-4. PubMed ID: 6952119 [No Abstract] [Full Text] [Related]
33. Neuroleptic-induced catatonia: case report. Johnson GC; Manning DE J Clin Psychiatry; 1983 Aug; 44(8):310-2. PubMed ID: 6874654 [TBL] [Abstract][Full Text] [Related]
34. A double-blind comparative trial of loxapine and trifluoperazine in acute and chronic schizophrenic patients. Kiloh LG; Williams SE; Grant DA; Whetton PS J Int Med Res; 1976; 4(6):441-8. PubMed ID: 800384 [TBL] [Abstract][Full Text] [Related]
35. A controlled double-blind comparison between loxapine succinate and chlorpromazine in acute newly hospitalized schizophrenic patients. Shopsin B; Pearson E; Gershon S; Collins P Curr Ther Res Clin Exp; 1972 Nov; 14(11):739-48. PubMed ID: 4629112 [No Abstract] [Full Text] [Related]
36. A double-blind comparison between loxapine and haloperidol by parenteral route in acute schizophrenia. Paprocki J; Versiani M Curr Ther Res Clin Exp; 1977 Jan; 21(1):80-100. PubMed ID: 12922 [No Abstract] [Full Text] [Related]
37. Antipsychotic properties of loxapine succinate. Gershon S; Hekimian LJ; Burdock EI; Kim SS Curr Ther Res Clin Exp; 1970 May; 12(5):280-5. PubMed ID: 4986243 [No Abstract] [Full Text] [Related]
38. Is loxapine more effective than chlorpromazine in paranoid schizophrenia? Rifkin A; Rieder E; Sarantakos S; Saraf K; Kane J Am J Psychiatry; 1984 Nov; 141(11):1411-3. PubMed ID: 6388362 [TBL] [Abstract][Full Text] [Related]
39. A double-blind comparison between loxapine and chlordiazepoxide in the treatment of neurotic anxiety. Versiani M; Bueno JR; Mundim FD; da Silva JA; Rocha AV Curr Ther Res Clin Exp; 1976 Nov; 20(5):701-15. PubMed ID: 825357 [No Abstract] [Full Text] [Related]
40. Loxapine versus haloperidol parenterally in acute psychosis with agitation. A double-blind study. Fruensgaard K; Korsgaard S; Jorgensen H; Jensen K Acta Psychiatr Scand; 1977 Oct; 56(4):256-64. PubMed ID: 335787 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]